Literature DB >> 19120353

Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.

Armin Finkenstedt1, Paola Bianchi, Igor Theurl, Wolfgang Vogel, Derrick R Witcher, Victor J Wroblewski, Anthony T Murphy, Alberto Zanella, Heinz Zoller.   

Abstract

Iron absorption is inadequately increased in patients with chronic haemolytic anaemia, which is commonly complicated by iron overload. Growth differentiation factor 15 (GDF15) has been identified as a bone marrow-derived factor that abrogates hepcidin-mediated protection from iron overload under conditions of increased erythropoiesis. Increased concentrations of GDF15 have been reported in beta-thalassaemia patients and GDF15 has been found to suppress hepcidin expression in vitro. To further study the interdependencies of iron metabolism and erythropoiesis in vivo, the concentrations of hepcidin and GDF15 were determined in sera from 22 patients with pyruvate kinase deficiency (PKD) and 21 healthy control subjects. In PKD patients, serum hepcidin levels were 13-fold lower than in controls (2.0 ng/ml vs. 26.2 ng/ml) and GDF15 was significantly higher (859 pg/ml vs. 528 pg/ml). Serum hepcidin concentrations correlated positively with haemoglobin and negatively with serum GDF15. These results suggest that GDF15 contributes to low hepcidin expression and iron loading in PKD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120353     DOI: 10.1111/j.1365-2141.2008.07535.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  23 in total

1.  Need for early recognition and therapeutic guidelines of congenital sideroblastic anaemia.

Authors:  M L H Cuijpers; D J van Spronsen; P Muus; B C J Hamel; D W Swinkels
Journal:  Int J Hematol       Date:  2011-06-08       Impact factor: 2.490

Review 2.  Regulation of erythropoiesis by hypoxia-inducible factors.

Authors:  Volker H Haase
Journal:  Blood Rev       Date:  2013-01-03       Impact factor: 8.250

Review 3.  Growth differentiation factor 15 in erythroid health and disease.

Authors:  Toshihiko Tanno; Pierre Noel; Jeffery L Miller
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

Review 4.  Molecular mechanisms of normal iron homeostasis.

Authors:  An-Sheng Zhang; Caroline A Enns
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

5.  Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Bertil Glader; Hitoshi Kanno; Archana Agarwal; Wilma Barcellini; Stefan Eber; James D Hoyer; David J Kuter; Tabita Magalhães Maia; Maria Del Mar Mañu-Pereira; Theodosia A Kalfa; Serge Pissard; José-Carlos Segovia; Eduard van Beers; Patrick G Gallagher; David C Rees; Richard van Wijk
Journal:  Am J Hematol       Date:  2018-11-28       Impact factor: 10.047

6.  Iron Loading and Overloading due to Ineffective Erythropoiesis.

Authors:  Toshihiko Tanno; Jeffery L Miller
Journal:  Adv Hematol       Date:  2010-05-11

Review 7.  Concise review: growth differentiation factor 15 in pathology: a clinical role?

Authors:  Jill Corre; Benjamin Hébraud; Philippe Bourin
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

8.  The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice.

Authors:  Guillem Casanovas; Maja Vujić Spasic; Carla Casu; Stefano Rivella; Jens Strelau; Klaus Unsicker; Martina U Muckenthaler
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

9.  Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.

Authors:  Rui Cui; Robert Peter Gale; Guoqing Zhu; Zefeng Xu; Tiejun Qin; Yue Zhang; Gang Huang; Bing Li; Liwei Fang; Hongli Zhang; Lijuan Pan; Naibo Hu; Shiqiang Qu; Zhijian Xiao
Journal:  Leuk Res       Date:  2014-02-10       Impact factor: 3.156

Review 10.  What can we learn from ineffective erythropoiesis in thalassemia?

Authors:  Paraskevi Rea Oikonomidou; Stefano Rivella
Journal:  Blood Rev       Date:  2017-10-03       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.